Austar Lifesciences Dirección
Dirección controles de criterios 3/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Mars Ho
Chief Executive Officer (CEO)
CN¥935.0k
Compensación total
| Porcentaje del salario del CEO | 98.3% |
| Permanencia del CEO | 10.8yrs |
| Participación del CEO | 66.3% |
| Permanencia media de la dirección | 10.4yrs |
| Promedio de permanencia en la Junta Directiva | 10.4yrs |
Actualizaciones recientes de la dirección
Recent updates
Austar Lifesciences Limited's (HKG:6118) Share Price Boosted 32% But Its Business Prospects Need A Lift Too
Oct 16
Investors Aren't Buying Austar Lifesciences Limited's (HKG:6118) Revenues
Aug 28We Think Shareholders May Want To Consider A Review Of Austar Lifesciences Limited's (HKG:6118) CEO Compensation Package
May 24Revenues Working Against Austar Lifesciences Limited's (HKG:6118) Share Price Following 30% Dive
Apr 18Would Austar Lifesciences (HKG:6118) Be Better Off With Less Debt?
Mar 28Investors Still Aren't Entirely Convinced By Austar Lifesciences Limited's (HKG:6118) Revenues Despite 25% Price Jump
Feb 12Market Cool On Austar Lifesciences Limited's (HKG:6118) Revenues
Dec 22We Think Austar Lifesciences (HKG:6118) Has A Fair Chunk Of Debt
Sep 28Here's Why Austar Lifesciences (HKG:6118) Has A Meaningful Debt Burden
Mar 31Austar Lifesciences Limited (HKG:6118) Stock's 29% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Sep 19Is Austar Lifesciences (HKG:6118) A Risky Investment?
Apr 06Austar Lifesciences (HKG:6118) Has A Pretty Healthy Balance Sheet
Oct 24With EPS Growth And More, Austar Lifesciences (HKG:6118) Is Interesting
Sep 27If You Like EPS Growth Then Check Out Austar Lifesciences (HKG:6118) Before It's Too Late
May 31Austar Lifesciences (HKG:6118) Seems To Use Debt Quite Sensibly
Mar 31Is Now The Time To Put Austar Lifesciences (HKG:6118) On Your Watchlist?
Mar 01Austar Lifesciences Limited (HKG:6118) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?
Feb 01
Are Austar Lifesciences's (HKG:6118) Statutory Earnings A Good Guide To Its Underlying Profitability?
Jan 11Austar Lifesciences (HKG:6118) Seems To Use Debt Quite Sensibly
Dec 21Can You Imagine How Jubilant Austar Lifesciences' (HKG:6118) Shareholders Feel About Its 191% Share Price Gain?
Dec 07Here's What Austar Lifesciences Limited's (HKG:6118) Shareholder Ownership Structure Looks Like
Nov 23Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -CN¥19m |
| Mar 31 2024 | n/a | n/a | -CN¥26m |
| Dec 31 2023 | CN¥935k | CN¥919k | -CN¥33m |
| Jun 30 2023 | n/a | n/a | CN¥51m |
| Mar 31 2023 | n/a | n/a | CN¥78m |
| Dec 31 2022 | CN¥895k | CN¥880k | CN¥104m |
| Sep 30 2022 | n/a | n/a | CN¥96m |
| Jun 30 2022 | n/a | n/a | CN¥105m |
| Mar 31 2022 | n/a | n/a | CN¥191m |
| Dec 31 2021 | CN¥865k | CN¥850k | CN¥277m |
| Sep 30 2021 | n/a | n/a | CN¥258m |
| Jun 30 2021 | n/a | n/a | CN¥238m |
| Mar 31 2021 | n/a | n/a | CN¥136m |
| Dec 31 2020 | CN¥927k | CN¥911k | CN¥33m |
| Sep 30 2020 | n/a | n/a | CN¥25m |
| Jun 30 2020 | n/a | n/a | CN¥17m |
| Mar 31 2020 | n/a | n/a | CN¥12m |
| Dec 31 2019 | CN¥918k | CN¥902k | CN¥8m |
| Sep 30 2019 | n/a | n/a | CN¥8m |
| Jun 30 2019 | n/a | n/a | CN¥8m |
| Mar 31 2019 | n/a | n/a | CN¥4m |
| Dec 31 2018 | CN¥880k | CN¥865k | CN¥107k |
| Sep 30 2018 | n/a | n/a | -CN¥16m |
| Jun 30 2018 | n/a | n/a | -CN¥33m |
| Mar 31 2018 | n/a | n/a | -CN¥43m |
| Dec 31 2017 | CN¥1m | CN¥1m | -CN¥54m |
Compensación vs. Mercado: La compensación total de Mars ($USD129.16K) está por debajo de la media de empresas de tamaño similar en el mercado Hong Kong ($USD233.13K).
Compensación vs. Ingresos: La compensación de Mars ha aumentado mientras la empresa no es rentable.
CEO
Mars Ho (62 yo)
10.8yrs
Permanencia
CN¥935,000
Compensación
Mr. Kwok Keung Ho, also known as Mars, is the Founder of Austar Lifesciences Limited and serves as its Chairman of the Board and Chief Executive Officer. Mr. Ho is responsible for overseeing the business,...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Founder | no data | CN¥935.00k | 66.27% HK$ 224.2m | |
| Executive Director | 10.4yrs | CN¥2.13m | sin datos | |
| Executive Director | 10.4yrs | CN¥1.11m | sin datos | |
| Executive Director | 10.4yrs | CN¥2.26m | 7.27% HK$ 24.6m | |
| Vice President of Corporate Development | 3.9yrs | sin datos | sin datos | |
| Company Secretary | 2.1yrs | sin datos | sin datos |
10.4yrs
Permanencia media
58yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de 6118 es experimentado (10.4 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Founder | 10.8yrs | CN¥935.00k | 66.27% HK$ 224.2m | |
| Executive Director | 10.4yrs | CN¥2.13m | sin datos | |
| Executive Director | 10.4yrs | CN¥1.11m | sin datos | |
| Executive Director | 10.8yrs | CN¥2.26m | 7.27% HK$ 24.6m | |
| Independent Non-Executive Director | 10.1yrs | CN¥161.00k | sin datos | |
| Independent Non-Executive Director | 7.1yrs | CN¥161.00k | sin datos | |
| Independent Non-Executive Director | 10.1yrs | CN¥161.00k | sin datos | |
| Non-Executive Director | 10.4yrs | CN¥632.00k | sin datos |
10.4yrs
Permanencia media
51.5yo
Promedio de edad
Junta con experiencia: Los miembros de la junta directiva de 6118 son experimentados ( 10.4 años antigüedad media).